Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Receivables (2016 - 2025)

Historic Receivables for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to $379000.0.

  • Firefly Neuroscience's Receivables changed N/A to $379000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $379000.0, marking a year-over-year change of. This contributed to the annual value of $354000.0 for FY2024, which is 2465.32% up from last year.
  • Per Firefly Neuroscience's latest filing, its Receivables stood at $379000.0 for Q3 2025.
  • In the past 5 years, Firefly Neuroscience's Receivables registered a high of $3.7 million during Q2 2022, and its lowest value of $100000.0 during Q1 2025.
  • Over the past 5 years, Firefly Neuroscience's median Receivables value was $1.5 million (recorded in 2021), while the average stood at $1.4 million.
  • Its Receivables has fluctuated over the past 5 years, first surged by 15693.56% in 2021, then plummeted by 8801.94% in 2025.
  • Over the past 5 years, Firefly Neuroscience's Receivables (Quarter) stood at $1.9 million in 2021, then dropped by 2.13% to $1.8 million in 2022, then crashed by 84.55% to $280000.0 in 2023, then increased by 26.43% to $354000.0 in 2024, then grew by 7.06% to $379000.0 in 2025.
  • Its Receivables was $379000.0 in Q3 2025, compared to $397000.0 in Q2 2025 and $100000.0 in Q1 2025.